Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis.
Pseudothrombocytopenia (PTP) is the phenomenon of falsely low platelet counts due to in vitro platelet clumping in the presence of platelet autoantibodies and anticoagulants. We assessed anticoagulant-dependence, time course of platelet counts and impact of different counter devices on the phenomenon. Blood of 10 persons with previously recognized pronounced EDTA-dependent PTP was collected into 7 different anticoagulants and counted after different intervals in parallel in a Coulter T540 and a Coulter STKS counter and by phase contrast microscopy. With the Coulter T540 model PTP was most pronounced in blood samples anticoagulated with EDTA, Na-oxalate or Na-citrate. In the STKS counter EDTA, heparin and oxalate presented as the worst anticoagulants. The time course of platelet counts was significantly different between the two counters. Our results demonstrate that PTP is not restricted to EDTA, but is also present with other anticoagulants. In contrast, pseudoleucocytosis was observed only in EDTA-anticoagulated blood in the Coulter T540 device. We investigated the expression of platelet integrins and activation antigens on platelets of persons with anticoagulant-dependent PTP and in healthy controls without PTP. In the presence of EDTA the expression of GpIIb/IIIa was significantly reduced in the PTP subjects compared to control. Activation antigens CD62, CD63 and thrombospondin-antigen were upregulated in the presence of EDTA. These alterations in the expression of platelet antigens could also be induced on platelets of normal donors by incubation with sera of PTP subjects and EDTA.(ABSTRACT TRUNCATED AT 250 WORDS)
Schrezenmeier
H
H
Department of Medicine III, University of Ulm, Germany.
Müller
H
H
Gunsilius
E
E
Heimpel
H
H
Seifried
E
E
D000925:Anticoagulants / Q000494:pharmacology*; D015703:Antigens, CD / Q000032:analysis; D016477:Artifacts; D002449:Cell Aggregation / Q000187:drug effects; D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid; D003951:Diagnostic Errors; D004492:Edetic Acid / Q000494:pharmacology; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D016023:Integrins / Q000032:analysis; D007958:Leukocyte Count / Q000187:drug effects* / Q000295:instrumentation; D007964:Leukocytosis / Q000175:diagnosis*; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis; D008858:Microscopy, Phase-Contrast; D008875:Middle Aged; D010070:Oxalates / Q000494:pharmacology; D019007:P-Selectin; D015539:Platelet Activation; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count / Q000187:drug effects* / Q000295:instrumentation; D010980:Platelet Membrane Glycoproteins / Q000032:analysis; D060149:Tetraspanin 30; D013921:Thrombocytopenia / Q000175:diagnosis*; D019699:Thrombospondins
D000925:Anticoagulants; D015703:Antigens, CD; C554586:CD63 protein, human; D002951:Citrates; D016023:Integrins; D008562:Membrane Glycoproteins; D010070:Oxalates; D019007:P-Selectin; D010980:Platelet Membrane Glycoproteins; D060149:Tetraspanin 30; D019699:Thrombospondins; D019343:Citric Acid; D006493:Heparin; D004492:Edetic Acid